Minerva Neurosciences NERV
NASDAQ NERV
$2.45 -0.08 (-2.96%)
As of: Oct 21, 2026 · 2:28 PM EDT

Minerva Neurosciences (NERV) Net Margin (2014 - 2020)

Updated

Minerva Neurosciences (NERV) recorded Net Margin of 4.71% in FY2020.

Analysis

Minerva Neurosciences (NERV) Net Margin (2014 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,135.59 Bn 1,104.17 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 616.92 Bn 535.45 Bn 17.26 Bn 21.86%
3 AbbVie 501.52 Bn 474.63 Bn 12.70 Bn 21.27%
4 Merck 367.36 Bn 321.74 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.93 Bn 261.92 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 16.30%
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn 23.62%
8 Gilead Sciences 190.72 Bn 164.92 Bn 6.22 Bn -134.51%
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn -1.65%
10 Minerva Neurosciences 113.24 Mn -134.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 71.72%
Dec 31, 2014 -248,072,066.67%
API Access

Minerva Neurosciences Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=NERV&period=max&api_key=YOUR_API_KEY